Clinical Trial Update: Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating adverse events when ubrogepant is used in combination with atogepant to treat episodic migraine in adults; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Qulipta (atogepant)
• Ubrelvy (ubrogepant)

Snippet

Sponsor: AbbVie | Conditions: Episodic Migraine | Phase 4 | Status: COMPLETED | Results posted: 2024-10-08